BNP Paribas Financial Markets’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25 | Buy |
5
+1
| +25% | +$5 | ﹤0.01% | 4568 |
|
|
2025
Q1 | $32 | Hold |
4
| – | – | ﹤0.01% | 4471 |
|
|
2024
Q4 | $30 | Hold |
4
| – | – | ﹤0.01% | 4484 |
|
|
2024
Q3 | $38 | Hold |
4
| – | – | ﹤0.01% | 3365 |
|
|
2024
Q2 | $50 | Hold |
4
| – | – | ﹤0.01% | 3309 |
|
|
2024
Q1 | $87 | Buy |
+4
| New | +$87 | ﹤0.01% | 3300 |
|
|
2022
Q4 | – | Sell |
-3
| Closed | -$2.38K | – | 3420 |
|
|
2022
Q3 | $2.38K | Buy |
+3
| New | +$2.38K | ﹤0.01% | 3614 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | -$9.75K | – | 3409 |
|
|
2021
Q2 | $9.75K | Sell |
1
-1
| -50% | -$9.75K | ﹤0.01% | 3135 |
|
|
2021
Q1 | $17.4K | Hold |
2
| – | – | ﹤0.01% | 3210 |
|
|
2020
Q4 | $17.9K | Sell |
2
-1
| -33% | -$8.97K | ﹤0.01% | 3206 |
|
|
2020
Q3 | $21.1K | Buy |
3
+2
| +200% | +$14.1K | ﹤0.01% | 3194 |
|
|
2020
Q2 | $6.79K | Sell |
1
-1
| -50% | -$6.79K | ﹤0.01% | 3251 |
|
|
2020
Q1 | $17K | Buy |
2
+1
| +100% | +$8.49K | ﹤0.01% | 3326 |
|
|
2019
Q4 | $16.2K | Buy |
+1
| New | +$16.2K | ﹤0.01% | 3381 |
|
|
2019
Q3 | – | Hold |
0
| – | -$299 | – | 3667 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3810 |
|